Citation Impact
Citing Papers
Autophagy Is Required for Glucose Homeostasis and Lung Tumor Maintenance
2014
Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study
2009
A Central Role for RAF→MEK→ERK Signaling in the Genesis of Pancreatic Ductal Adenocarcinoma
2012
Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green
2018 StandoutNobel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma
2015
SLC46A3 as a Potential Predictive Biomarker for Antibody–Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads
2018
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
2016 StandoutNobel
Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment
2015
The interaction between SPARC and GRP78 interferes with ER stress signaling and potentiates apoptosis via PERK/eIF2α and IRE1α/XBP-1 in colorectal cancer
2019
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Resistance to the Antibody–Drug Conjugate T-DM1 Is Based in a Reduction in Lysosomal Proteolytic Activity
2017
Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study
2018
Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3)
2018
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study
2017
Cancer immunotherapy: the beginning of the end of cancer?
2016
Regulatory networks define phenotypic classes of human stem cell lines
2008 Nature
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Mechanism and medical implications of mammalian autophagy
2018 Standout
Combination cancer immunotherapy and new immunomodulatory targets
2015
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis
2013
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Free Energy Calculations by the Molecular Mechanics Poisson−Boltzmann Surface Area Method
2012
Selective discussion and transparency in microarray research findings for cancer outcomes
2007
MGMT Methylation Status: The Advent of Stratified Therapy in Glioblastoma?
2007
Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
2014
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Multiplexed protein measurement: technologies and applications of protein and antibody arrays
2006
The biology and function of fibroblasts in cancer
2016 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Metastatic Pancreatic Cancer Is Dependent on Oncogenic Kras in Mice
2012
Hepatocellular carcinoma
2021 Standout
CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity
2019 StandoutNobel
Molecular Dynamics Simulation for All
2018 Standout
Brain tumors: molecular biology and targeted therapies
2006
Microenvironment Determines Lineage Fate in a Human Model of MLL-AF9 Leukemia
2008
Quantification of Murine Pancreatic Tumors by High-Resolution Ultrasound
2012
Evaluating the potency of HIV‐1 protease drugs to combat resistance
2007
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
Epigenetics in Cancer
2008 Standout
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Pancreatic Adenocarcinoma
2014 Standout
The use of combinations of monoclonal antibodies in clinical oncology
2015
Immune-mediated mechanisms influencing the efficacy of anticancer therapies
2015
Targeting apoptosis in cancer therapy
2020 Standout
Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer
2016
Malignant Gliomas in Adults
2008 Standout
Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates
2016
Inhibiting kinases in malignant gliomas
2007
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer
2019
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis
2011
Gastric cancer
2020 Standout
Modeling and predicting clinical efficacy for drugs targeting the tumor milieu
2012
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Targeting autophagy in cancer
2017 Standout
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
New cancer targets emerging from studies of the Von Hippel‐Lindau tumor suppressor protein
2010 StandoutNobel
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
2014 Standout
Mouse models of advanced spontaneous metastasis for experimental therapeutics
2011
Neutrophils in cancer: neutral no more
2016 Standout
The PI3K Pathway in Human Disease
2017 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
A phase I study of cabozantinib (XL184) in patients with renal cell cancer
2014 StandoutNobel
Predictive in vivo animal models and translation to clinical trials
2012
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
2017 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Promises and Challenges of Smac Mimetics as Cancer Therapeutics
2015
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
Targeting SOD1 reduces experimental non–small-cell lung cancer
2013
Surface-Enhanced Raman Spectroscopy for Bioanalysis: Reliability and Challenges
2018 Standout
Molecular Dynamics Investigation on a Series of HIV Protease Inhibitors: Assessing the Performance of MM-PBSA and MM-GBSA Approaches
2012
Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF–induced neutrophil recruitment
2013
The Pancreas Cancer Microenvironment
2012
Synthesis and Biological Evaluations of a Series of Thaxtomin Analogues
2015
Unlocking Reactivity of TrpB: A General Biocatalytic Platform for Synthesis of Tryptophan Analogues
2017 StandoutNobel
Combinatorial Action of MicroRNAs let-7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation
2015
FRET Reagent Reveals the Intracellular Processing of Peptide-Linked Antibody–Drug Conjugates
2018
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Molecular Alterations and Everolimus Efficacy in Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancers: Combined Exploratory Biomarker Analysis From BOLERO-1 and BOLERO-3
2016
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Metabolic reprogramming and cancer progression
2020 StandoutScience
A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects
2008
Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors
2014
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
2009 StandoutScience
Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations
2010 Standout
IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
2010
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
g_mmpbsa—A GROMACS Tool for High-Throughput MM-PBSA Calculations
2014 Standout
Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti‐cancer antibodies: IUPHAR Review 18
2016
Works of Ron Yu being referenced
Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial
2014
A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer
2014
Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein
2006
Dogs Are More Sensitive to Antagonists of Inhibitor of Apoptosis Proteins Than Rats and Humans: A Translational Toxicokinetic/Toxicodynamic Analysis
2012
A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors
2014
A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors
2014
Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models
2010
Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T‐DM1) vs. treatment of physician's choice in previously treated HER2‐positive advanced breast cancer
2016
Abstract S5-05: Trastuzumab emtansine improves overall survival versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer: Final overall survival results from the phase 3 TH3RESA study
2016
Tumor Necrosis Factor-α–Induced Protein 3 As a Putative Regulator of Nuclear Factor-κB–Mediated Resistance to O6-Alkylating Agents in Human Glioblastomas
2005
Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes
2004
Phase I study of safety and pharmacokinetics (PK) of GDC-0917, an antagonist of inhibitor of apoptosis (IAP) proteins in patients (Pts) with refractory solid tumors or lymphoma.
2013
Molecular Dynamics and Free Energy Studies on the Wild-type and Double Mutant HIV-1 Protease Complexed with Amprenavir and Two Amprenavir-Related Inhibitors: Mechanism for Binding and Drug Resistance
2007
A Phase I Dose-Escalation Study Evaluating the Safety Tolerability and Pharmacokinetics of CUDC-427, a Potent, Oral, Monovalent IAP Antagonist, in Patients with Refractory Solid Tumors
2016